Author

S. Faisal

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:development & morphogenesis· 1 Assay:flow cytometry· 1 Organism:mouse· 1

Frequent Co-Authors

A. Aliseda· 1 shared A. Mohan· 1 shared A. Singh· 1 shared A. Taher· 1 shared B. D. Ratner· 1 shared B. S. Fountaine· 1 shared B. W. Johnson· 1 shared C. Gao· 1 shared

Activity by Year

2020-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. Aliseda

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Immunomodulatory Porous Regenerative Scaffolds for in situ Vascular Engineering

L. Zhen, E. Quiroga, S. A. Creason, N. Chen, T. R. Sapre, J. M. Snyder, S. L. Lindhartsen, B. S. Fountaine, M. C. Barbour, S. Faisal, A. Aliseda, B. W. Johnson, J. Himmelfarb, B. D. Ratner

This study demonstrates that immunomodulatory porous scaffolds improve vascular graft healing by promoting endothelialization and transmural cellular infiltration compared to standard PTFE grafts.

Biomaterials · Sep 1, 2025Peer-reviewedBioengineering

Chronic hyperglycemia drives alterations in macrophage effector function in pulmonary tuberculosis

S. Panda, D. M. Seelan, S. Faisal, K. Luthra, J. K. Palanichamy, A. Mohan, N. K. Vikram, N. K. Gupta, L. Ramakrishnan, A. Singh

This study examines how chronic hyperglycemia affects macrophage effector functions in pulmonary tuberculosis, finding reduced phagocytic capacity and altered PRR expression in diabetic TB patients.

bioRxiv · Jan 18, 2022Immunology

G-CSF SECRETED BY EPIGENETICALLY REPROGRAMMED MUTANT IDH1 GLIOMA STEM CELLS REVERSES THE MYELOID CELLS'-MEDIATED IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT

M. S. Alghamri, R. Avvari, R. Thalla, N. Kamran, L. Zhang, M. Ventosa, A. Taher, S. Faisal, F. Nunez, M. Garcia-Fabiani, S. Haase, S. Carney, D. Orringer, S. Hervey-Jumper, J. Heth, , M. G. Castro

The paper shows that mIDH1 glioma stem cells secrete G-CSF, which reprograms myeloid cells to become non-immunosuppressive, altering the tumor microenvironment.

bioRxiv · Jul 22, 2020 · PreprintCancer Biology